Five SFU research projects—from creating a new centre for wearable biomedical technologies to studies in immersive remote sensing communication— will benefit from $21.7 million in new infrastructure funding from the Canada Foundation for Innovation (CFI). The federal contribution is expected to more than double over the next five years from partner contributions. The Innovation Fund supports transformative infrastructure projects that underpin promising and innovative research…
Read More
Forty years ago, two papers described the first tractable methods for determining the order of the chemical bases in stretches of DNA. Before these 1977 publications, molecular biologists had been able to sequence only snippets. The evolution of DNA sequencing from these nascent protocols to today’s high-throughput technologies has occurred at a breathtaking pace. Nearly 30 years of exponential growth in…
Read More
Program Leader Dr. Aly Karsan and Principal Investigators Drs Connie Eaves, Andrew Weng, Martin Hirst, have been awarded nearly $7.5 million over 5 years from the Terry Fox Research Institute (TFRI) for the Terry Fox New Frontier Program Project Grant in Exploiting Pathogenic Mechanisms in Acute Leukemia for Clinical Translation.   The overall long-term goal of this Program is to better…
Read More
At the EATRIS’ Translational Medicine 2017 Conference, and at the height of Global Biotech Week, it was announced that five of the world’s top translational science organizations representing the European Union, the United Kingdom, the United States, Canada, and Australia have joined forces under the new banner of Translation Together. This new collaboration will enable the leveraging of complementary scientific and…
Read More
Oncogenic gene fusions involving Neuregulin 1 (NRG1) have been described as recurrent aberrations in lung adenocarcinomas and had been proposed to represent a druggable signaling axis but this hypothesis had yet to be tested. In the overall POG project, we identified two patients with NRG1 fusion-positive cancers. The first had a primary lung adenocarcinoma, while the second had a primary intrahepatic cholangiocarcinoma, a disease type in which NRG1 fusions have not…
Read More
Congratulations to Bruce McManus for being awarded the UBC Faculty of Medicine Bill and Marilyn Webber Lifetime Achievement Award! The award is made in recognition of sustained scholarly achievement in the areas of research, teaching and/or service and honours extraordinary members of the Faculty of Medicine who have had sustained distinguished careers at UBC. Dr. McManus joined the Faculty of…
Read More
Dr. Bryce Taylor, Chair of the Canadian Medical Hall of Fame (CMHF) announced today that Dr. B. Brett Finlay was among six new laureates who have been selected for induction into the Canadian Medical Hall of Fame. Finlay is a Professor in the Michael Smith Laboratories, with joint appointments in the Department of Microbiology & Immunology, and the Department of Biochemistry and Molecular…
Read More
This week, Conversations That Matter features the remarkable Dr. Allen Eaves, the founder, CEO and President of STEMCELL Technologies, Canada’s most successful biotech company. A firm that is playing a pivotal role in fostering a community of biotech startups. Eaves says, “we’re very keen to support an ecosystem of biotechnology here and be closely related with the universities, especially UBC…
Read More

From Patient to Survivor: Madeline’s Inspiration to Study Pediatric Cancer

In 2012, 14-year-old Madeline Lauener received a stem cell transplant from her sister as treatment for a rare type of blood cancer. Five years later, she’s at BC Children’s Hospital, taking part in research that aims to help kids diagnosed with cancer. “I joined the Summer Student Research Program because I wanted to learn and be involved in the cancer…
Read More
his is a major Canadian study performed by the Canadian BMT Group and including centres from Canada, Saudi Arabia, New Zealand, and Australia. We found that two donor immune cells suppress chronic graft-versus-host disease (cGvHD) and will be used to guide interventions to minimize development of the disease. It also has resulted in a new focus on NKregs, an immune regulatory…
Read More